Ionis Pharmaceuticals Inc SEC filings IONS

Ionis Pharmaceuticals Inc has 1,005 filings in SEC EDGAR's recent list, going back to Jul 6, 2020. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 29, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Ionis Pharmaceuticals Inc SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
Oct 23, 2026 Oct 23, 2026
8-K Current report
Regulation FD disclosure, Other events
Oct 21, 2026 Oct 20, 2026
4 Insider transaction Oct 19, 2026 Oct 15, 2026
4 Insider transaction Oct 19, 2026 Oct 15, 2026
144 Notice of proposed sale Oct 16, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Sep 23, 2026 Sep 23, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 4, 2026 Sep 4, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 4, 2026 Sep 3, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Jul 31, 2026 Jul 30, 2026
S-8 Employee stock plan registration Jul 31, 2026 —
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
8-K Current report
Regulation FD disclosure
Jul 10, 2026 Jul 9, 2026
4 Insider transaction Jul 9, 2026 Jul 7, 2026
4 Insider transaction Jul 9, 2026 Jul 7, 2026
4 Insider transaction Jul 9, 2026 Jul 7, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 9, 2026 Jul 9, 2026
144 Notice of proposed sale Jul 7, 2026 —
144 Notice of proposed sale Jul 7, 2026 —
144 Notice of proposed sale Jul 7, 2026 —
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 1, 2026 —
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 25, 2026
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 25, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jun 24, 2026 Jun 24, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 12, 2026 —
8-K Current report
Other events
Jun 12, 2026 Jun 12, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
3 Initial insider ownership Jun 8, 2026 Jun 4, 2026
3 Initial insider ownership Jun 8, 2026 Jun 4, 2026
8-K Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
8-K Current report
Regulation FD disclosure, Other events
May 28, 2026 May 28, 2026
4 Insider transaction May 15, 2026 May 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
144 Notice of proposed sale May 13, 2026 —
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 5, 2026 May 1, 2026
144 Notice of proposed sale May 4, 2026 —
4 Insider transaction Apr 30, 2026 Apr 28, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
10-Q Quarterly report Apr 29, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 29, 2026 Apr 29, 2026
144 Notice of proposed sale Apr 28, 2026 —
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 4, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 21, 2026 Apr 21, 2026
4 Insider transaction Apr 17, 2026 Apr 15, 2026
4 Insider transaction Apr 17, 2026 Apr 15, 2026
4 Insider transaction Apr 17, 2026 Apr 15, 2026
4 Insider transaction Apr 17, 2026 Apr 15, 2026
144 Notice of proposed sale Apr 16, 2026 —
144 Notice of proposed sale Apr 16, 2026 —
144 Notice of proposed sale Apr 16, 2026 —
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 2, 2026
144 Notice of proposed sale Mar 31, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
144/A Filing Mar 24, 2026 —
4 Insider transaction Mar 23, 2026 Mar 19, 2026
144 Notice of proposed sale Mar 19, 2026 —
4 Insider transaction Mar 18, 2026 Mar 16, 2026
144 Notice of proposed sale Mar 16, 2026 —
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 10, 2026
144 Notice of proposed sale Mar 10, 2026 —
144 Notice of proposed sale Mar 9, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 9, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
144/A Filing Mar 3, 2026 —
144 Notice of proposed sale Mar 3, 2026 —
144 Notice of proposed sale Mar 3, 2026 —
144 Notice of proposed sale Mar 3, 2026 —
144 Notice of proposed sale Mar 3, 2026 —
144 Notice of proposed sale Mar 3, 2026 —
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4/A Primary document Feb 13, 2026 Feb 2, 2026
4 Insider transaction Feb 13, 2026 Feb 13, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
144 Notice of proposed sale Feb 13, 2026 —
144 Notice of proposed sale Feb 11, 2026 —
4 Insider transaction Feb 10, 2026 Feb 6, 2026
144 Notice of proposed sale Feb 6, 2026 —
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Jan 30, 2026 —
144 Notice of proposed sale Jan 30, 2026 —
144 Notice of proposed sale Jan 30, 2026 —
144 Notice of proposed sale Jan 30, 2026 —
144 Notice of proposed sale Jan 30, 2026 —
144 Notice of proposed sale Jan 30, 2026 —
144 Notice of proposed sale Jan 30, 2026 —
144 Notice of proposed sale Jan 30, 2026 —
4 Insider transaction Jan 23, 2026 Jan 22, 2026
144/A Filing Jan 23, 2026 —
144 Notice of proposed sale Jan 22, 2026 —
144 Notice of proposed sale Jan 21, 2026 —
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4/A Primary document Jan 20, 2026 Jan 2, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
144 Notice of proposed sale Jan 16, 2026 —
144 Notice of proposed sale Jan 16, 2026 —
144 Notice of proposed sale Jan 16, 2026 —
144 Notice of proposed sale Jan 16, 2026 —
144 Notice of proposed sale Jan 16, 2026 —
144 Notice of proposed sale Jan 16, 2026 —
144 Notice of proposed sale Jan 16, 2026 —
144 Notice of proposed sale Jan 16, 2026 —
144 Notice of proposed sale Jan 16, 2026 —
144 Notice of proposed sale Jan 16, 2026 —
144 Notice of proposed sale Jan 16, 2026 —
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jan 7, 2026 Jan 7, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
3 Initial insider ownership Jan 6, 2026 Dec 21, 2025
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
144 Notice of proposed sale Jan 2, 2026 —
4 Insider transaction Dec 3, 2025 Dec 1, 2025
144/A Filing Dec 1, 2025 —
144 Notice of proposed sale Dec 1, 2025 —
4 Insider transaction Nov 28, 2025 Nov 25, 2025
4 Insider transaction Nov 28, 2025 Nov 25, 2025
144 Notice of proposed sale Nov 25, 2025 —
144 Notice of proposed sale Nov 25, 2025 —
4 Insider transaction Nov 20, 2025 Nov 18, 2025
4 Insider transaction Nov 20, 2025 Nov 19, 2025
144 Notice of proposed sale Nov 19, 2025 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Nov 17, 2025 Nov 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IONS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
CA
Headquarters
Carlsbad, CA
SEC filer status
Large accelerated filer
SEC CIK
874015
Former names
ISIS PHARMACEUTICALS INC (until Dec 18, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.